Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

EVMN US Equity

Evommune, Inc.Health Care · Pharmaceutical Preparations · CIK 2044725 · FY ends Dec 31
$15.01
+0.79 (+5.56%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Andera Partnerssec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-308-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-1613GSchedule 13G filed — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-16

Every row is a filed document, checked against its EDGAR index.